3-(3-Methyl-5-oxo-4,5-dihydro-pyrazol-1-yl)-benzoic acid, 500mg

2-Bromo-4-chlorobenzotrifluoride, 96.0%, 10g

(3-Bromobenzyl)methylamine, 97.0%, 25g

3,4,5-Trichloropyridin-2-amine, 95.0%, 5g

7-Methoxy-4-methyl-2,3-dihydro-1H-inden-1-one, 95.0%, 5g

3-Bromo-5-phenylpyridine>98.0%(GC)(T)1g

2-(4-Chloro-2-(trifluoromethyl)phenyl)acetonitrile, 95.0%, 1g

Pointes de pipettes epT.IPS® 0,2-5 ml, 300 pièces

8-BOC-2-OXA-5,8-DIAZASPIRO[3.5]NONANE, 95.0%, 5g

N-Methyl-L-proline, 95.0%, 25g

C-((S)-1-Methyl-pyrrolidin-2-yl)-methylamine, 95.0%, 500mg

Ethyl 4-methanesulfonylcinnamate, 98%, 100mg

(2S,3S)-4-(anthracen-9-yl)-3-(tert-butyl)-2-methyl-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97.00%, 100mg